MagBiosense Revenue and Competitors
Estimated Revenue & Valuation
- MagBiosense's estimated annual revenue is currently $930k per year.
- MagBiosense's estimated revenue per employee is $155,000
Employee Data
- MagBiosense has 6 Employees.
- MagBiosense grew their employee count by 0% last year.
MagBiosense's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder | Reveal Email/Phone |
MagBiosense Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $79.1M | 510 | 6% | N/A | N/A |
#2 | $1.1M | 7 | 17% | N/A | N/A |
#3 | $4.2M | 27 | -32% | N/A | N/A |
#4 | $2M | 13 | 30% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $0.9M | 6 | 0% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $3.7M | 24 | 4% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $6M | 39 | 50% | N/A | N/A |
What Is MagBiosense?
MagBiosense, Inc. is a private, medical device company focused on the development of a breakthrough high-sensitivity, diagnostic device for use at the point-of-care. MagBiosense is the first to offer both ultra-high sensitivity and the convenience of a point-of-care (POC) device. Our Magnetic Modulation Biosensing (MMB) technology uniquely combines magnetic and fluorescent labeling of target biomarkers, such as cTnI, and applies an external magnetic field to increase fluorescence sensitivity. MMB reduces the diagnosis time of a heart attack by 65%, and thereby offering faster treatment, reduced ED dwell times, and decreased costs.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.6M | 6 | 0% | N/A |
#3 | $0.4M | 6 | 0% | N/A |
#4 | $0.4M | 6 | 0% | N/A |
#5 | $0.1M | 6 | 0% | $9.7M |